SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-15-001741
Filing Date
2015-03-16
Accepted
2015-03-16 16:54:46
Documents
3
Period of Report
2015-03-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20150316.htm 8-K 28864
2 EX-99.1 abio-ex991_2015031614.htm EX-99.1 24956
3 GRAPHIC g201503162005250695603.jpg GRAPHIC 216495
  Complete submission text file 0001564590-15-001741.txt   353563
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 15703618
SIC: 2835 In Vitro & In Vivo Diagnostic Substances